HASUMI INTERNAT RES FOUNDATION has a total of 13 patent applications. Its first patent ever was published in 2005. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and Brazil. Its main competitors in its focus markets pharmaceuticals and biotechnology are COLLATERAL THERAPEUTICS INC, IMMUNE DESIGN CORP and CHILDRENS HOSPITAL OF EASTERN ONTARIO RES INSTITUTE INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 5 | |
#2 | EPO (European Patent Office) | 2 | |
#3 | Brazil | 1 | |
#4 | China | 1 | |
#5 | Republic of Korea | 1 | |
#6 | Mexico | 1 | |
#7 | Singapore | 1 | |
#8 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Microorganisms | |
#4 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Hasumi Kenichiro | 12 |
#2 | Kuraya Mikio | 1 |
#3 | Kenichiro Hasumi | 1 |
Publication | Filing date | Title |
---|---|---|
WO2015077532A1 | Therapy and methods of introducing immature dendritic cells and/or cytotoxic t lymphocyte and anti-tnf antibody for treatment of tumors | |
US2014004126A1 | Therapy and method for intratumorally introducing cytotoxic T lymphocyte and/or NKT cell with anti-TNF and/or anti-IL-10 | |
WO2008063837A2 | Dendritic cell tumor injection therapy and related vaccine |